
    
      This is a dose-escalation study of Low-dose Radiation in combination with CS1001 in relapsed
      SCLC patients. Patients are assigned to 3 treatment groups received from 3 Gy to 15Gy, to
      determine the safety, tolerability and the maximal tolerant dose. Biomarkers and
      immunological markers are collected and analyzed as well.
    
  